SAFETY OF INACTIVATED POLYMER-SUBUNIT THREE VALENCE INFLUENZA VACCINE. POSTREGISTRATIONAL OBSERVATION
Clinical trial for polymer-subunit trivalent influenza vaccine Grippol plus reactogenicity assessment in 153 children aged 3-17 years old was conducted in the frames of post-registration studies. Prior to the vaccination the written informed agreement was signed by every participant' parent. In...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2009-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Clinical trial for polymer-subunit trivalent influenza vaccine Grippol plus reactogenicity assessment in 153 children aged 3-17 years old was conducted in the frames of post-registration studies. Prior to the vaccination the written informed agreement was signed by every participant' parent. In post-vaccination period physical examination and thermometry was performed daily in post-immunization days 1-5, on days 21-28 and then on a monthly basis for 4 months. Study results demonstrated that Grippol plus possesses low reactogenicity and can be applied in pediatrics for immunization in accordance with National Immunization schedule.Key words: children, influenza, vaccination.(Voprosy sovremennoi pediatrii - Current Pediatrics. 2009;8(4):37-41) |
|---|---|
| Item Description: | 1682-5527 1682-5535 |